Hypercalcemia of malignancy

Gregory R. Mundy, Theresa Guise

Research output: Contribution to journalArticle

146 Citations (Scopus)

Abstract

The hypercalcemia of malignancy is a topic that has undergone major changes in the past decade. Before that time, there was considerable controversy over the relative roles of different mediators, on the difficulties in differential diagnosis from the other nonparathyroid causes of hypercalcemia and from primary hyperparathyroidism, and debate over the place of various medical therapies. This review focuses on some of the current issues that face clinicians treating patients with this common complication of the most common malignancies.

Original languageEnglish (US)
Pages (from-to)134-145
Number of pages12
JournalThe American Journal of Medicine
Volume103
Issue number2
DOIs
StatePublished - Aug 1997
Externally publishedYes

Fingerprint

Hypercalcemia
Primary Hyperparathyroidism
Neoplasms
Differential Diagnosis
Therapeutics

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Hypercalcemia of malignancy. / Mundy, Gregory R.; Guise, Theresa.

In: The American Journal of Medicine, Vol. 103, No. 2, 08.1997, p. 134-145.

Research output: Contribution to journalArticle

Mundy, Gregory R. ; Guise, Theresa. / Hypercalcemia of malignancy. In: The American Journal of Medicine. 1997 ; Vol. 103, No. 2. pp. 134-145.
@article{17a51999fa0d4d748e172dd886b42fa5,
title = "Hypercalcemia of malignancy",
abstract = "The hypercalcemia of malignancy is a topic that has undergone major changes in the past decade. Before that time, there was considerable controversy over the relative roles of different mediators, on the difficulties in differential diagnosis from the other nonparathyroid causes of hypercalcemia and from primary hyperparathyroidism, and debate over the place of various medical therapies. This review focuses on some of the current issues that face clinicians treating patients with this common complication of the most common malignancies.",
author = "Mundy, {Gregory R.} and Theresa Guise",
year = "1997",
month = "8",
doi = "10.1016/S0002-9343(97)80047-2",
language = "English (US)",
volume = "103",
pages = "134--145",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Hypercalcemia of malignancy

AU - Mundy, Gregory R.

AU - Guise, Theresa

PY - 1997/8

Y1 - 1997/8

N2 - The hypercalcemia of malignancy is a topic that has undergone major changes in the past decade. Before that time, there was considerable controversy over the relative roles of different mediators, on the difficulties in differential diagnosis from the other nonparathyroid causes of hypercalcemia and from primary hyperparathyroidism, and debate over the place of various medical therapies. This review focuses on some of the current issues that face clinicians treating patients with this common complication of the most common malignancies.

AB - The hypercalcemia of malignancy is a topic that has undergone major changes in the past decade. Before that time, there was considerable controversy over the relative roles of different mediators, on the difficulties in differential diagnosis from the other nonparathyroid causes of hypercalcemia and from primary hyperparathyroidism, and debate over the place of various medical therapies. This review focuses on some of the current issues that face clinicians treating patients with this common complication of the most common malignancies.

UR - http://www.scopus.com/inward/record.url?scp=0030756221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030756221&partnerID=8YFLogxK

U2 - 10.1016/S0002-9343(97)80047-2

DO - 10.1016/S0002-9343(97)80047-2

M3 - Article

VL - 103

SP - 134

EP - 145

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 2

ER -